Literature DB >> 16424500

Cannabis and psychosis.

David M Fergusson1, Richie Poulton, Paul F Smith, Joseph M Boden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16424500      PMCID： PMC1336774          DOI： 10.1136/bmj.332.7534.172

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  21 in total

1.  Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia.

Authors:  P Miller; S M Lawrie; A Hodges; R Clafferty; R Cosway; E C Johnstone
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2001-07       Impact factor: 4.328

2.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Authors:  Louise Arseneault; Mary Cannon; Richie Poulton; Robin Murray; Avshalom Caspi; Terrie E Moffitt
Journal:  BMJ       Date:  2002-11-23

3.  Testing hypotheses about the relationship between cannabis use and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall; Michael Lynskey
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

Review 4.  Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies.

Authors:  John Macleod; Rachel Oakes; Alex Copello; Ilana Crome; Matthias Egger; Mathew Hickman; Thomas Oppenkowski; Helen Stokes-Lampard; George Davey Smith
Journal:  Lancet       Date:  2004-05-15       Impact factor: 79.321

5.  Cannabis as a risk factor for psychosis: systematic review.

Authors:  David M Semple; Andrew M McIntosh; Stephen M Lawrie
Journal:  J Psychopharmacol       Date:  2005-03       Impact factor: 4.153

Review 6.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

Review 7.  Cannabinoid physiology and pharmacology: 30 years of progress.

Authors:  Allyn C Howlett; Christopher S Breivogel; Steven R Childers; Samuel A Deadwyler; Robert E Hampson; Linda J Porrino
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

8.  Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.

Authors:  M Steffens; C Engler; J Zentner; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

9.  Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

Authors:  Joseph F Cheer; Kate M Wassum; Michael L A V Heien; Paul E M Phillips; R Mark Wightman
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

10.  Cannabis use and psychosis: a longitudinal population-based study.

Authors:  J van Os; M Bak; M Hanssen; R V Bijl; R de Graaf; H Verdoux
Journal:  Am J Epidemiol       Date:  2002-08-15       Impact factor: 4.897
View more
  30 in total

1.  Cannabis confusions.

Authors:  Geoff Watts
Journal:  BMJ       Date:  2006-01-21

2.  Cannabis and psychosis: let's start from the null hypothesis.

Authors:  D B Double
Journal:  BMJ       Date:  2006-02-04

3.  Cannabis and psychosis: Does cannabis really cause psychosis?

Authors:  Alasdair J Macdonald
Journal:  BMJ       Date:  2006-02-04

4.  Early intervention in psychosis: keeping the body in mind.

Authors:  David Shiers; Peter B Jones; Steve Field
Journal:  Br J Gen Pract       Date:  2009-06       Impact factor: 5.386

5.  Adolescent cannabis use increases risk for cocaine-induced paranoia.

Authors:  Rasmon Kalayasiri; Joel Gelernter; Lindsay Farrer; Roger Weiss; Kathleen Brady; Ralitza Gueorguieva; Henry R Kranzler; Robert T Malison
Journal:  Drug Alcohol Depend       Date:  2009-11-26       Impact factor: 4.492

Review 6.  Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study.

Authors:  David M Fergusson; Joseph M Boden; L John Horwood
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-26       Impact factor: 4.328

7.  Premorbid Personality Disorders in Male Schizophrenic Patients with or without Comorbid Substance Use Disorder: Is Dual Diagnosis Mediated by Personality Disorder?

Authors:  Neslihan Altunsoy; Şafak Yalçın Şahiner; Merve Cingi Külük; Tuncer Okay; Semra Ulusoy Kaymak; Çiğdem Aydemir; Erol Göka
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

8.  New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids.

Authors:  Paul F Smith
Journal:  Ther Clin Risk Manag       Date:  2010-03-03       Impact factor: 2.423

9.  Police-registered offenses and psychiatric disorders among young males : the Finnish "From a boy to a man" birth cohort study.

Authors:  Henrik Elonheimo; Solja Niemelä; Kai Parkkola; Petteri Multimäki; Hans Helenius; Ari-Matti Nuutila; Andre Sourander
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-04-21       Impact factor: 4.328

Review 10.  The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-06-19       Impact factor: 13.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.